Rejected at 9:51 p.m. May, 29, 2024 ] by herstein.jacob
Author: DharavP
Related Note: 1496498154874
Rationale for change

Doxycycline is used still, but is only used as an alternate to Fluoroquinolone, and you only swap this for elderly. Uworld explains.

(Choices C, D, and E) This patient requires hospitalization due to his CURB-65 score, which indicates a higher risk of morbidity and mortality. Moxifloxacin can be used as monotherapy for inpatients with CAP, but a beta-lactam plus macrolides/doxycycline is preferred for elderly patients due to increased risk of adverse events.
Source: UWorld - Step 2 4024

Rejection reason

UW chart supports current version of card

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::#SketchyIM::09_Infectious_Diseases::02_Lung_Infections::02_Pneumonia_Management #AK_Step2_v12::#OME::01_Medicine::06_Infectious_Disease::07_Pneumonia #AK_Step2_v12::#OME_banner #AK_Step2_v12::#OME_banner::Clinical::06_Infectious_Disease::07_Pneumonia #AK_Step2_v12::!Shelf::EM #PANCE::EOR::Family_med #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::17_Fluoroquinolones #AK_Step1_v12::#Physeo::06_Micro::02_Bacteria::50_Mycoplasma_Pneumoniae #AK_Step2_v12::#Subjects::Pulmonology::05_Lungs::Infection::Pneumonia::Management #AK_Step2_v12::#UWorld::COMLEX::100815 #AK_Step2_v12::#UWorld::Step::4024 #AK_Step2_v12::#Resources_by_rotation::IM::uw::pulm_critical_care::pulm_critical_care_zanki #PANCE::EOR::PEDS #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step1_v12::#Physeo::06_Micro::02_Bacteria::37_Legionella_Pneumophila #AK_Step2_v12::#B&B::08_Infectious_Disease::01_Antibiotics::02_Beta_Lactams::Extra #AK_Step2_v12::Original_decks::Dorian::im::uw::pulm_cc #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::4fm #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::25_Empiric_Antibiotics_in_Respiratory_and_ENT_Diseases #AK_Step2_v12::!Shelf::IM::no_dupes::only_step2 #AK_Step2_v12::#Resources_by_rotation::IM::emma #AK_Step2_v12::#Resources_by_rotation::IM::uw::pulm_critical_care::pulm_critical_care_dorian #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#Resources_by_rotation::FM::ome::infection::pna #AK_Step2_v12::#Resources_by_rotation::IM::ome::infection::pna #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::Pulm_&_Critical_Care #AK_Step1_v12::#OME_banner #PANCE::EOR::IM #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::06_Pneumonia #AK_Step2_v12::#AMBOSS::mj0VaT #PANCE::PULM::infectious_disorders #AK_Step3_v12::#UWorld::5545